Status:

NOT_YET_RECRUITING

Virtual Reality Exposure Therapy for Gambling Disorder

Lead Sponsor:

University Hospital, Lille

Collaborating Sponsors:

Ministry of Health, France

Conditions:

Gambling Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Gambling disorder (GD) is recognized as an addictive disorder in the DSM-5. Craving is a core phenomenon in addiction that can lead to relapse in problem gambling for pathological gamblers. Exposure T...

Detailed Description

Main aim: Show, within patients seeking care for GD, that VRET integrated with CBT is non-inferior to imaginal ET integrated with CBT on GD symptom reduction at the end of 12 treatment sessions. Sec...

Eligibility Criteria

Inclusion

  • Seek treatment for GD within one of health care facilities participating in the research (first request for treatment and not patients already receiving treatment for gambling disorder in the care center).
  • Meet a current diagnosis of gambling disorder according to DSM-5 criteria and with a South Oaks Gambling Screen (SOGS) score ≥ 5
  • Meet a casino gambling behavior with a casino gambling frequency ≥ 1 time every two months during the last 12 months
  • Have a sufficient understanding of French for therapy
  • Beneficiary of the French social security system
  • Give an informed consent to participate
  • Willing to comply with all study procedures and duration

Exclusion

  • Visual disturbance making impossible the use of virtual reality equipment (e.g. advanced retinal degeneration, central scotoma, age-related macular degeneration)
  • Pregnant woman
  • Minor or adult under guardianship, conservatorship, under judicial protection, persons deprived of their liberty
  • Balance disorder (e.g. cerebellar disorder, inner ear disorder)
  • Photosensitive epilepsy
  • Refusal to participate

Key Trial Info

Start Date :

January 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2026

Estimated Enrollment :

124 Patients enrolled

Trial Details

Trial ID

NCT04467502

Start Date

January 1 2024

End Date

July 1 2026

Last Update

January 26 2024

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

CHU Amiens-Picardie

Amiens, France

2

CH Boulogne sur mer CSAPA

Boulogne-sur-Mer, France

3

CHU de Caen

Caen, France

4

Hôpital Fontan, CHU lille

Lille, France, 59000